Adimmune Corporation (TPE:4142)

Adimmune Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 10, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	7,693	8,472	13,973	15,184	19,178	24,095
Market Cap Growth	-20.65%	-39.37%	-7.97%	-20.83%	-20.41%	162.50%
Enterprise Value	9,305	9,597	14,915	15,538	18,258	23,372
Last Close Price	18.25	20.10	33.15	35.60	44.65	55.59
PE Ratio	-	-	-	52.18	445.31	19.41
Forward PE	-	172.64	172.64	131.85	-	72.81
PS Ratio	6.40	5.44	7.83	6.74	10.69	12.89
PB Ratio	1.59	1.52	2.42	2.32	2.98	3.64
P/TBV Ratio	1.64	1.63	2.58	2.51	3.16	3.88
P/FCF Ratio	-	19.37	-	-	-	13.50
P/OCF Ratio	-	12.67	-	-	-	10.38
EV/Sales Ratio	7.75	6.16	8.36	6.90	10.18	12.50
EV/EBITDA Ratio	-	-	-	47.56	121.11	128.94
EV/EBIT Ratio	-	-	-	166.06	-	-
EV/FCF Ratio	-18.27	21.94	-	-	-	13.10
Debt / Equity Ratio	0.67	0.47	0.54	0.35	0.21	0.20
Debt / EBITDA Ratio	-	-	-	6.62	8.26	7.05
Debt / FCF Ratio	-	5.94	-	-	-	0.74
Asset Turnover	0.14	0.17	0.19	0.26	0.22	0.25
Inventory Turnover	1.23	1.53	1.83	1.92	2.60	3.41
Quick Ratio	1.24	2.31	2.13	7.06	10.44	8.64
Current Ratio	1.85	3.11	2.63	8.97	12.78	9.61
Return on Equity (ROE)	-11.46%	-5.93%	-12.50%	2.25%	0.22%	22.91%
Return on Assets (ROA)	-4.50%	-2.08%	-4.85%	0.68%	-0.41%	-0.21%
Return on Invested Capital (ROIC)	-10.03%	-4.92%	-11.75%	1.64%	-1.29%	-0.58%
Return on Capital Employed (ROCE)	-9.30%	-4.10%	-9.40%	1.10%	-0.70%	-0.30%
Earnings Yield	-6.61%	-2.86%	-4.58%	1.92%	0.22%	5.15%
FCF Yield	-6.62%	5.16%	-9.09%	-4.69%	-6.91%	7.41%
Dividend Yield	-	-	-	-	-	0.90%
Payout Ratio	-	-	-	-	498.66%	-
Buyback Yield / Dilution	-	-	1.44%	0.45%	-4.77%	-32.11%
Total Shareholder Return	-	-	1.44%	0.45%	-4.77%	-31.21%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.